Optiscan Biomedical Corporation · Class II · Cleared Feb 5, 2020
| K-number | K192785 |
| Device name | OptiScanner® 5000 Glucose Monitoring System |
| Applicant | Optiscan Biomedical Corporation |
| Product code | LZF |
| Device class | Class II |
| Decision date | Feb 5, 2020 |
| Decision | Substantially Equivalent |
| Regulation | 880.5725 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov